Patent Application for Reducing Food Intake Using Plants
Summary
The USPTO has published a new patent application (US20260083800A1) detailing methods and compositions using Dichrostachys glomerata or Cissus quadrangularis to reduce food intake or appetite in mammals. The application was filed on September 26, 2024, by inventors Shil Kothari and Julius Enyoug Oben.
What changed
This document is a publication of a patent application filed with the USPTO, specifically application number US20260083800A1. The application, titled "METHODS AND COMPOSITIONS FOR REDUCING FOOD INTAKE OR APPETITE IN A MAMMAL USING NATURALLY OCCURING PLANTS AND SPICES," describes the use of Dichrostachys glomerata or Cissus quadrangularis to potentially increase GLP-1 levels and reduce food intake, visceral fat, blood lipids, total cholesterol, and total glucose in mammals.
As this is a patent application, it does not impose direct regulatory obligations or compliance deadlines on regulated entities. However, it signifies potential future developments in the pharmaceutical and food industries related to appetite suppression and weight management. Companies involved in developing or marketing related products should monitor the progress of this patent application and any resulting granted patents.
Archived snapshot
Mar 26, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
METHODS AND COMPOSITIONS FOR REDUCING FOOD INTAKE OR APPETITE IN A MAMMAL USING NATURALLY OCCURING PLANTS AND SPICES
Application US20260083800A1 Kind: A1 Mar 26, 2026
Inventors
Shil Kothari, Julius Enyoug Oben
Abstract
Methods and compositions using Dichrostachys glomerata or Cissus quadrangularis separately to provide a variety of health benefits, including but not limited to, increase GLP-1 levels and reduce or decrease visceral fat, food intake, blood lipids, total cholesterol and total glucose in a mammal. In one embodiment, a composition for reducing food intake or appetite in a mammal is provided where the composition comprises an effective amount of Dichrostachys glomerata provided as an oral dosage unit in the form of a pill, capsule, liquid, lozenge or tablet.
CPC Classifications
A61K 36/48 A61P 3/04 A61K 2236/17 A61K 2236/33
Filing Date
2024-09-26
Application No.
18898550
Related changes
Get daily alerts for USPTO Patent Applications - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.